RBC Capital Reiterates Sector Perform on Gilead Sciences, Maintains $74 Price Target
Portfolio Pulse from Benzinga Newsdesk
RBC Capital analyst Brian Abrahams has reiterated a Sector Perform rating on Gilead Sciences (NASDAQ:GILD) and maintained a $74 price target.
July 01, 2024 | 2:00 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
RBC Capital analyst Brian Abrahams has reiterated a Sector Perform rating on Gilead Sciences and maintained a $74 price target.
The reiteration of a Sector Perform rating and maintenance of the $74 price target by RBC Capital suggests a neutral outlook for Gilead Sciences in the short term. This indicates that the stock is expected to perform in line with the sector, and no significant price movement is anticipated based on this news alone.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100